ERBB2 and breast carcinoma: In the present study, we investigated the prognostic utilities and most suitable cut-off values for Ki67 LI and PgR expression, and then analyzed the relationship between Ki67 LI and PgR expression as a prognostic marker in patients with ER-positive/HER2-negative breast cancer.